Light therapy for mild to moderate Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests a light therapy that shines near-infrared light on the head to see if it can improve memory and thinking in people with mild to moderate Alzheimer's disease. It is an early-stage trial, so the main goal is to check safety and see if the treatment shows promise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 90 years old.
- You have a diagnosis of mild to moderate Alzheimer's disease (based on memory and thinking tests).
- You score between 12 and 26 on a memory and thinking questionnaire called the MMSE.
- You are able to read and complete cognitive tests (at least primary school education level).
- If you take memory medications, the dose has been stable for at least 3 months (or 1 month for psychiatric medications).
- You are not taking blood thinners, and you have no history of seizures or bleeding strokes in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special near-infrared light device, combined with the medication lecanemab, can help people with mild Alzheimer's disease. It aims to see if the light therapy can slow down memory loss and improve daily function.
This study tests a new treatment that uses 40-Hz light and sound stimulation to potentially improve brain function in people with early Alzheimer's disease or mild cognitive impairment. It aims to see if this non-invasive therapy can help slow down memory loss and thinking problems.
This study tests whether regular at-home “gamma” light and sound stimulation can help people with mild Alzheimer’s. Participants start with a month at home and are followed to see how they do during treatment.
This study tests whether regular “gamma” light and sound stimulation can delay or prevent Alzheimer’s disease-related memory decline in people who are currently not showing dementia but are at higher risk. It uses brain testing (MRI and PET) and memory/language tests over about 13 months.
This trial tests whether a combination of 40 Hz light stimulation and cognitive (thinking) therapy can improve symptoms in people with Alzheimer’s disease. It may help by stimulating the brain and training thinking skills, while carefully checking eye and seizure history.
This study tests if a near-infrared light therapy device can help improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves daily treatment sessions with the device, and a study partner must be available to help with treatment.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.